These results indicate that DCs generated with IL-15, especially those in the IL-15 mDCs (6 days) group, had a stronger immunomodulatory effect that could promote the Th1 polarization of allogeneic naïve CD4+ T cells and indirectly suppress regulatory T cells via mDCs in MM patients. This evidence concerns the gene CD4 and Miyoshi myopathy.